New to Meducation?
Sign up
Already signed up? Log In

Category

1
1
9

MTPL1 2007 | Case 01 presented by Kenneth K Ng, MD

MeetTheProfessors.com – 51-year-old woman, never smoked, diagnosed with Stage IIB NSCLC with two positive lymph nodes; patient underwent a lobectomy, and an EGFR gene analysis revealed an exon 21 point mutation  
Dr Neil Love
over 8 years ago
9
1
15

VPB2_2010 | Case01

ResearchToPractice.com/VPB210 – A 65-yo woman presents with a 2.1-cm, poorly differentiated, strongly ER+, PR-, HER2- BC with micrometastasis in the sentinel node and an Oncotype DX Recurrence Score of 36. Interview conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 8 years ago
10
1
15

VPB2_2010 | Case02

ResearchToPractice.com/VPB210 – A 38-yo woman presents with a primary ER-negative, HER2-positive BC and hepatic and bone metastases. Interview conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 8 years ago
11
1
21

VPB2_2010 | Case03

ResearchToPractice.com/VPB210 –A 62-yo woman has an ER+, HER2- lobular carcinoma encompassing the left breast and a right pleural effusion and peritoneal stranding on CT scan. Interview conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 8 years ago
12
1
14

VPB2_2010 | Case04

ResearchToPractice.com/VPB210 – A 28-yo woman with a 2.5-cm, Grade II, ER/PR+, HER2- breast tumor is enrolled on the BETH trial of adjuvant chemo and trastuzumab with or without bevacizumab. Interview conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 8 years ago
13
1
22

VPB2_2010 | Case05

ResearchToPractice.com/VPB210 – A 51-yo woman with a 3-cm, Grade II, strongly ER/PR+, HER2- IDC has 17/18 positive axillary nodes and 4 satellite breast nodules. Interview conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 8 years ago
0
1
25

VPB2_2010 | Case06

ResearchToPractice.com/VPB210 – A 65-yo woman has bone and hepatic metastases after 4 years of treatment with adjuvant letrozole for a 1.2-cm, ER+, HER2-, node- IDC. Interview conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 8 years ago
2
1
19

VPB1_2010 | Case02

ResearchToPractice.com/VPB110 – A 52yo premenopausal woman develops erythematous, ulcerated, ER/PR+, HER2+ BC while receiving AC>TH and tamoxifen for contralateral BC. Interview conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 8 years ago
3
1
19

VPB1_2010 | Case03

<p>ResearchToPractice.com/VPB110 – A 77yo woman presents with a 10-cm, Grad <br />III, weakly ER/PR+, HER2-equivocal, node+ IDC and questionable liver and bone mets. Interview conducted by Neil Love, MD. Produced by Research To Practice.</p>  
Dr Neil Love
over 8 years ago
4
1
23

VPB1_2010 | Case04

ResearchToPractice.com/VPB110 – A 50yo premenopausal woman has locally advanced ER+, HER2- IDC and widespread mets to the bone, lung and brain. Interview conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 8 years ago
5
2
12

VPB1_2010 | Case05

ResearchToPractice.com/VPB110 – A 54yo woman with bipolar disorder is diagnosed with a 1.6-cm, Grade III, strongly ER+, weakly PR+, HER2-, node- IDC and an Oncotype DX RS of 32. Interview conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 8 years ago
6
1
9

VPB1_2010 | Case06

ResearchToPractice.com/VPB110 – A 54yo woman develops painful, biopsyconfirmed triple-negative sternal mets 7 years after completion of adjuvant dose-dense AC paclitaxel. Interview conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 8 years ago
7
1
12

VPB2 2009 | Case 1

ResearchToPractice.com/VPB209 - Case 1: A 41-year-old woman with a metastatic ER-positive, HER2-negative invasive ductal carcinoma (IDC) after being treated two years ago with neoadjuvant AC followed by T, mastectomy, radiation therapy and tamoxifen. Interviews conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 8 years ago
8
1
19

VPB2 2009 | Case 2

ResearchToPractice.com/VPB209 - Case 2: A 59-year-old woman with bone metastases two years after the diagnosis of a Grade II, node-positive, ER-positive, PR-positive, HER2-positive IDC. Interviews conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 8 years ago
9
1
15

VPB2 2009 | Case 3

ResearchToPractice.com/VPB209 - Case 3: A 72-year-old woman with cancer recurrence nine years after diagnosis of a 1-cm, poorly differentiated, node-positive, ER-positive, PR-negative, HER2-negative IDC. Interviews conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 8 years ago
10
1
4

VPB2 2009 | Case 4

ResearchToPractice.com/VPB209 - Case 4: A 51-year-old postmenopausal woman diagnosed five years ago with 4-cm and 1-cm node-positive, ER-positive, HER2-negative IDCs. Interviews conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 8 years ago
11
1
11

VPB2 2009 | Case 5

ResearchToPractice.com/VPB209 - Case 5: A woman diagnosed nine years ago at the age of 42 with a 9-cm, ER-positive, PR-positive, HER2-positive IDC who has received multiple lines of therapy for metastatic disease. Interviews conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 8 years ago
12
1
22

VPB2 2009 | Case 6

ResearchToPractice.com/VPB209 - Case 6: A 51-year-old postmenopausal woman with a 1.3-cm, Grade II, node-negative, ER-positive, PR-positive, HER2-negative IDC and an Oncotype DX® Recurrence Score® of 21 (intermediate risk). Interviews conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 8 years ago
13
1
19

VPB2 2009 | Case 7

ResearchToPractice.com/VPB209 - Case 7: A 50-year-old woman with rising tumor markers and a PET scan-documented solitary lesion in her rib four years after being diagnosed with a T1cN2aM0, ER-positive (10 percent), HER2-negative IDC. Interviews conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 8 years ago
0
1
9

VPB2 2009 | Case 8

ResearchToPractice.com/VPB209 - Case 8: A 74-year-old woman with a cutaneous chest wall recurrence of metastatic ER-negative, PR-negative, HER2-positive inflammatory BC. Interviews conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 8 years ago